Elizabeth Crowley

Companies

• Celldex TherapeuticsSVP, Chief Product Dev Officer Aug 12, 2016 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Celldex Therapeutics CLDX9,074 shares²$268.1K at $29.55Jun 14, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 14, 2024Sold 30,000 shares at $34.87 of Celldex Therapeutics²
• Jun 14, 2024Exercised options 30,000 shares at $10.38 of Celldex Therapeutics²
• Jun 7, 2024Sold 15,000 shares at $35.06 of Celldex Therapeutics³
• Jun 7, 2024Exercised options 7,500 shares at $9.02 of Celldex Therapeutics³
• Jun 7, 2024Exercised options 7,500 shares at $10.38 of Celldex Therapeutics³
• May 30, 2024Sold 38,597 shares at $33.64 of Celldex Therapeutics⁴
• May 30, 2024Exercised options 8,500 shares at $9.02 of Celldex Therapeutics⁴
• May 30, 2024Exercised options 34,445 shares at $2.78 of Celldex Therapeutics⁴
• Dec 8, 2021Sold 4,000 shares at $40.00 of Celldex Therapeutics⁵
• Dec 8, 2021Exercised options 4,000 shares at $9.02 of Celldex Therapeutics⁵
• Nov 1, 2021Sold 1,189 shares at $41.62 of Celldex Therapeutics⁶
• Nov 1, 2021Sold 600 shares at $43.11 of Celldex Therapeutics⁶
• Nov 1, 2021Sold 2,528 shares at $44.12 of Celldex Therapeutics⁶
• Nov 1, 2021Exercised options 8,555 shares at $2.78 of Celldex Therapeutics⁶